Skip to main content

Federal Judge Blocks Roundup Label Warning Order in CA.

Federal Judge Blocks Roundup Label Warning Order in CA.

Federal Judge Blocks Roundup Label Warning Order in CA.

Introduction

U.S. District Judge William B. Shubb confirmed on June 11 that Roundup and other glyphosate-based weedkiller products in the state of California need not carry cancer risk warning labels, rejecting new arguments to amend the injunction.

The State's attorney general and director of the Office of Environmental Health Hazard Assessment (OEHHA), filed a motion to halt the introduction of warning labels in February. However, Judge Shubb dismissed the motion stating the injunction by the State was not purely factual and uncontroversial under the First Amendment and sided with Monsanto and other weed killer manufacturers.

The state and federal courts have several cases filed against Monsanto and other agricultural industry groups over cancer warning label requirements. More than 2,200 lawsuits are pending in the U.S. District Court in San Francisco, which are consolidated as a part of a multidistrict litigation (MDL No. 2741: In Re: Roundup Products Liability Litigation) under Judge Vince Chhabria. The first trial for a 46-year-old plaintiff, who is suffering from-Hodgkin Lymphoma(NHL) allegedly due to exposure to glyphosate, convened on June 18 in the Superior Court for the County of San Francisco.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!